Angiotensin-converting enzyme gene polymorphism in Behçet's disease

Clinical Rheumatology

Volumn 23, Issue 2, 2004, Pages 142-146

  Öztürk, M Akif ^a   Çalgüneri, Meral ^b   Kiraz, Sedat ^b   Ertenli, Ihsan ^b   Onat, Mesut ^b   Üreten, Kemal ^b   Özbalkan, Zeynep ^b   Haznedaroĝlu, Ibrahim C ^b  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme gene polymorphism; Beh et's disease; Renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DNA POLYMORPHISM; EYE DISEASE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE LOCATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SEX RATIO; SYMPTOMATOLOGY; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; COHORT STUDIES; DNA; ELECTROPHORESIS, AGAR GEL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 2342428404     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0853-8     Document Type: Article

References (45)

1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284-1291
2. Özoran K, Düzgün H, Gürler A, Tutkak H, Tokgöz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. Scand J Rheumatol 24:376-382
3. Haznedaroǧlu IC, Özdemir O, Özcebe O, Dündar SV, Kirazli Ş (1996) Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease. Thromb Haemost 75:974-975
4. Ertenli I, Kiraz S, Çelik I et al. (2001) Changes in the concentration and distribution of TFPI in Behçet's disease and SLE: impact on the prethrombotic state. Ann Rheum Dis 60:1149-1151
5. Haznedaroǧlu Ş, Karaaslan Y, Büyükasik Y et al. (2000) Selectin adhesion molecules in Behçet's disease. Ann Rheum Dis 59:61-63
6. Haznedaroǧlu IC, Dündar SV, Kirazli Ş (1995) Eicosanoids in the prethrombotic state of Behçet's disease. Thromb Res 80:445-446
7. Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. J Am Coll Cardiol 37:517-520
8. Kiraz S, Ertenli I, Çalgüneri M et al. (2001) Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol 19 (Suppl 24): S25-S29
9. Henrion D, Benessiano J, Levy BI (1997) In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery. Circ Res 80:189-195
10. Kranzhöfer R, Schmidt J, Pfeiffer CAH, Hagl S, Libby P, Kübler W (1999) Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19:1623-1629
11. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
12. Danser AH, Schalekamp MA, Bax WA et al. (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388
13. Soubrier F, Nadaud S, Williams TA (1994) Angiotensin I converting enzyme gene: Regulation, polymorphism and implications in cardiovascular diseases. Eur Heart J 15 (Suppl 4): 24-29
14. Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711
15. Pullmann R Jr, Lukac J, Skerenova M et al. (1999) Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol 17:593-596
16. Sato H, Akai Y, Iwano M et al. (1998) Association of an insertion polymorphism of angiotensin converting enzyme gene with the activity of systemic lupus erythematosus. Lupus 7:530-534
17. Akai Y, Sato H, Iwano M et al. (1999) Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol 51:141-146
18. Molad Y, Gal E, Magal N et al. (2000) Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum 30:132-137
19. Yoshioka T, Xu YX, Yoshida H, Shiraga H, Muraki T, Ito K (1998) Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis. Arch Dis Child 79:394-399
20. Amoroso A, Danek G, Vatta S et al. (1998) Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients. Italian Group of Renal Immunopathology. Nephrol Dial Transplant 13:3184-3188
21. Takeuchi K, Yamamoto K, Kataoka S et al. (1997) High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm. Eur J Pediatr 156:266-268
22. Murakozy G, Gaede KI, Ruprecht B et al. (2001) Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 79:665-670
23. International Study Group for Behcet's Disease (1990) Criteria for diagnosis of Behcet's disease. Lancet 335:1078-1080
24. Frishberg Y, Becker-Cohen R, Halle Det al. (1998) Genetic polymorphisms of the renin-angiotensin system and outcome of focal segmental glomerulosclerosis in children. Kidney Int 54:1843-1849
25. Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711
26. Altinbas A, Aytemur K, Tokgözoǧlu Let al. (2000) Hyperhomocysteinaemia and activated protein C resistance in Behç et's disease. J Intern Med 248:267-268
27. Dzau VJ (1988) Tissue renin-angiotensin systems: physiologic and pharmacological implications. Circulation 77(Suppl I): 11-13
28. Dzau VJ, Gibbons GH, Pratt RE (1991) Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension 18 (4 Suppl): II100-105
29. Erdos EG (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 16:363-370
30. Caldwell PR, Seegal BC, Hsu KC, Das M, Soffer RL (1976) Angiotensin-converting enzyme: vascular endothelial localization. Science 191:1050-1051
31. Arnal JF, Battle T, Rasetti C et al. (1994) ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 267:H1777-1784
32. Rogerson FM, Chai SY, Schlawe I, Murray WK, Marley PD, Mendelsohn FA (1992) Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 10:615-620
33. Muller DN, Bohlender J, Hilgers KFet al. (1997) Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 29:98-104
34. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J (2001) Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321-329
35. Owen CA, Campbell EJ (1998) Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 160:1436-1443
36. Gomez RA, Norling LL, Wilfong N et al. (1993) Leukocytes synthesize angiotensinogen. Hypertension 21:470-475
37. Brasier AR, Li J (1996) Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27:465-475
38. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ (1996) Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767
39. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40
40. Mancini GB, Henry GC, Macaya C et al. (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94:258-265
41. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R (1997) Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 100:678-684
42. Nakamura M, Funakoshi T, Yoshida H, Arakawa N, Suzuki T, Hiramori K (1992) Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J Cardiovasc Pharmacol 20:949-954
43. Prasad A, Narayanan S, Husain S et al. (2000) Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation 102:35-41
44. Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644
45. Mayer NJ, Forsyth A, Kantachuvesiri S, Mullins JJ, Fleming S (2002) Association of the D allele of the angiotensin I converting enzyme polymorphism with malignant vascular injury. Mol Pathol 55:29-33